Here are five things to know:
1. The company reported double-digit revenue growth in its spine, surgical specialties and cardiothoracic segments.
2. In the midst of a restructuring program, RTI expects to save $8 million annually starting in the second quarter of this year.
3. Worldwide revenues increased 4 percent from last year’s Q1 to this year’s $69.9 million.
4. Domestic revenues increased by 3 percent to $63.3 million while international revenue increased 8 percent to $6.6 million.
5. The company expects 2017 full-year revenue to be between $274 million and $285 million.
Camille Farhat, who became RTI CEO on March 15, 2017, said, “Although we are in the initial phases of this evaluation, there are three central themes that standout: 1. continue investment in our spine business and build scale; 2. increase investment in our commercial business to drive innovation and create new growth opportunities, and 3. improve margins of our tissue-based implants.”
More articles on devices:
Exactech Q1 2017 revenue hits $69.5M — 8 highlights
Dr. David Ruch performs 1st surgery using OsteoMATE arthrodesis implant — 4 key notes
Nexxt Spine releases INERTIA CORTI-FIXX pedicle screw system — 4 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
